Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes

Enrolling by invitationOBSERVATIONAL
Enrollment

6,500

Participants

Timeline

Start Date

May 6, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2027

Conditions
Diabetes Mellitus, Type 2Diabetes, Gestational
Interventions
OTHER

Whole genome sequencing

Each participant will have WGS performed in order to report on clinically actionable genetic variation in diabetes.

Trial Locations (5)

Unknown

Rigshospitalet, Copenhagen

Herlev Hospital, Herlev

Steno Diabetes Center Copenhagen, Herlev

Hillerød Hospital, Hillerød

Hvidovre Hospital, Hvidovre

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Steno Diabetes Center Copenhagen

OTHER

collaborator

BGI Europe

UNKNOWN

collaborator

Intomics A/S

UNKNOWN

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Danish National Genome Center

UNKNOWN

collaborator

Nordsjaellands Hospital

OTHER

collaborator

Herlev Hospital

OTHER

collaborator

Hvidovre University Hospital

OTHER

lead

University of Copenhagen

OTHER